������

������ Presents to FDA on Oversight Considerations for GenAI Medical Devices

The ������® presented at the U.S. FDA Digital Health Advisory Committee meeting “Total Product Lifecycle Considerations for Generative AI-Enabled Devices.” Bernardo Bizzo, MD, PhD, ������ Data Science Institute® Associate Chief Science Officer, represented the College at the meeting.

������ DSI Releases 2 New Non-Interpretive Reading Room Use Cases

use cases, artificial intelligence, reading room

Direct Supervision for Contrast Studies

We recommend that sites follow the ������ CT and MR Accreditation requirements for onsite supervision of contrast administration and management.